A phase I/II study of adoptive immunotherapy using donor liver graft-derived NK cell-enriched immune cells to prevent severe infection after liver transplantation

Saved in:
Bibliographic Details
Main Authors: Masahiro Ohira, Yuki Imaoka, Koki Sato, Koki Imaoka, Tomoaki Bekki, Takuya Yano, Ryosuke Nakano, Hiroshi Sakai, Shintaro Kuroda, Hiroyuki Tahara, Kentaro Ide, Tsuyoshi Kobayashi, Yuka Tanaka, Junko Tanaka, Hideki Ohdan
Format: Article
Language:English
Published: Public Library of Science (PLoS) 2025-01-01
Series:PLoS ONE
Online Access:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11737672/?tool=EBI
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1832592630673833984
author Masahiro Ohira
Yuki Imaoka
Koki Sato
Koki Imaoka
Tomoaki Bekki
Takuya Yano
Ryosuke Nakano
Hiroshi Sakai
Shintaro Kuroda
Hiroyuki Tahara
Kentaro Ide
Tsuyoshi Kobayashi
Yuka Tanaka
Junko Tanaka
Hideki Ohdan
author_facet Masahiro Ohira
Yuki Imaoka
Koki Sato
Koki Imaoka
Tomoaki Bekki
Takuya Yano
Ryosuke Nakano
Hiroshi Sakai
Shintaro Kuroda
Hiroyuki Tahara
Kentaro Ide
Tsuyoshi Kobayashi
Yuka Tanaka
Junko Tanaka
Hideki Ohdan
author_sort Masahiro Ohira
collection DOAJ
format Article
id doaj-art-30334ab8b4164935968dd932a4413394
institution Kabale University
issn 1932-6203
language English
publishDate 2025-01-01
publisher Public Library of Science (PLoS)
record_format Article
series PLoS ONE
spelling doaj-art-30334ab8b4164935968dd932a44133942025-01-21T05:31:40ZengPublic Library of Science (PLoS)PLoS ONE1932-62032025-01-01201A phase I/II study of adoptive immunotherapy using donor liver graft-derived NK cell-enriched immune cells to prevent severe infection after liver transplantationMasahiro OhiraYuki ImaokaKoki SatoKoki ImaokaTomoaki BekkiTakuya YanoRyosuke NakanoHiroshi SakaiShintaro KurodaHiroyuki TaharaKentaro IdeTsuyoshi KobayashiYuka TanakaJunko TanakaHideki Ohdanhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC11737672/?tool=EBI
spellingShingle Masahiro Ohira
Yuki Imaoka
Koki Sato
Koki Imaoka
Tomoaki Bekki
Takuya Yano
Ryosuke Nakano
Hiroshi Sakai
Shintaro Kuroda
Hiroyuki Tahara
Kentaro Ide
Tsuyoshi Kobayashi
Yuka Tanaka
Junko Tanaka
Hideki Ohdan
A phase I/II study of adoptive immunotherapy using donor liver graft-derived NK cell-enriched immune cells to prevent severe infection after liver transplantation
PLoS ONE
title A phase I/II study of adoptive immunotherapy using donor liver graft-derived NK cell-enriched immune cells to prevent severe infection after liver transplantation
title_full A phase I/II study of adoptive immunotherapy using donor liver graft-derived NK cell-enriched immune cells to prevent severe infection after liver transplantation
title_fullStr A phase I/II study of adoptive immunotherapy using donor liver graft-derived NK cell-enriched immune cells to prevent severe infection after liver transplantation
title_full_unstemmed A phase I/II study of adoptive immunotherapy using donor liver graft-derived NK cell-enriched immune cells to prevent severe infection after liver transplantation
title_short A phase I/II study of adoptive immunotherapy using donor liver graft-derived NK cell-enriched immune cells to prevent severe infection after liver transplantation
title_sort phase i ii study of adoptive immunotherapy using donor liver graft derived nk cell enriched immune cells to prevent severe infection after liver transplantation
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11737672/?tool=EBI
work_keys_str_mv AT masahiroohira aphaseiiistudyofadoptiveimmunotherapyusingdonorlivergraftderivednkcellenrichedimmunecellstopreventsevereinfectionafterlivertransplantation
AT yukiimaoka aphaseiiistudyofadoptiveimmunotherapyusingdonorlivergraftderivednkcellenrichedimmunecellstopreventsevereinfectionafterlivertransplantation
AT kokisato aphaseiiistudyofadoptiveimmunotherapyusingdonorlivergraftderivednkcellenrichedimmunecellstopreventsevereinfectionafterlivertransplantation
AT kokiimaoka aphaseiiistudyofadoptiveimmunotherapyusingdonorlivergraftderivednkcellenrichedimmunecellstopreventsevereinfectionafterlivertransplantation
AT tomoakibekki aphaseiiistudyofadoptiveimmunotherapyusingdonorlivergraftderivednkcellenrichedimmunecellstopreventsevereinfectionafterlivertransplantation
AT takuyayano aphaseiiistudyofadoptiveimmunotherapyusingdonorlivergraftderivednkcellenrichedimmunecellstopreventsevereinfectionafterlivertransplantation
AT ryosukenakano aphaseiiistudyofadoptiveimmunotherapyusingdonorlivergraftderivednkcellenrichedimmunecellstopreventsevereinfectionafterlivertransplantation
AT hiroshisakai aphaseiiistudyofadoptiveimmunotherapyusingdonorlivergraftderivednkcellenrichedimmunecellstopreventsevereinfectionafterlivertransplantation
AT shintarokuroda aphaseiiistudyofadoptiveimmunotherapyusingdonorlivergraftderivednkcellenrichedimmunecellstopreventsevereinfectionafterlivertransplantation
AT hiroyukitahara aphaseiiistudyofadoptiveimmunotherapyusingdonorlivergraftderivednkcellenrichedimmunecellstopreventsevereinfectionafterlivertransplantation
AT kentaroide aphaseiiistudyofadoptiveimmunotherapyusingdonorlivergraftderivednkcellenrichedimmunecellstopreventsevereinfectionafterlivertransplantation
AT tsuyoshikobayashi aphaseiiistudyofadoptiveimmunotherapyusingdonorlivergraftderivednkcellenrichedimmunecellstopreventsevereinfectionafterlivertransplantation
AT yukatanaka aphaseiiistudyofadoptiveimmunotherapyusingdonorlivergraftderivednkcellenrichedimmunecellstopreventsevereinfectionafterlivertransplantation
AT junkotanaka aphaseiiistudyofadoptiveimmunotherapyusingdonorlivergraftderivednkcellenrichedimmunecellstopreventsevereinfectionafterlivertransplantation
AT hidekiohdan aphaseiiistudyofadoptiveimmunotherapyusingdonorlivergraftderivednkcellenrichedimmunecellstopreventsevereinfectionafterlivertransplantation
AT masahiroohira phaseiiistudyofadoptiveimmunotherapyusingdonorlivergraftderivednkcellenrichedimmunecellstopreventsevereinfectionafterlivertransplantation
AT yukiimaoka phaseiiistudyofadoptiveimmunotherapyusingdonorlivergraftderivednkcellenrichedimmunecellstopreventsevereinfectionafterlivertransplantation
AT kokisato phaseiiistudyofadoptiveimmunotherapyusingdonorlivergraftderivednkcellenrichedimmunecellstopreventsevereinfectionafterlivertransplantation
AT kokiimaoka phaseiiistudyofadoptiveimmunotherapyusingdonorlivergraftderivednkcellenrichedimmunecellstopreventsevereinfectionafterlivertransplantation
AT tomoakibekki phaseiiistudyofadoptiveimmunotherapyusingdonorlivergraftderivednkcellenrichedimmunecellstopreventsevereinfectionafterlivertransplantation
AT takuyayano phaseiiistudyofadoptiveimmunotherapyusingdonorlivergraftderivednkcellenrichedimmunecellstopreventsevereinfectionafterlivertransplantation
AT ryosukenakano phaseiiistudyofadoptiveimmunotherapyusingdonorlivergraftderivednkcellenrichedimmunecellstopreventsevereinfectionafterlivertransplantation
AT hiroshisakai phaseiiistudyofadoptiveimmunotherapyusingdonorlivergraftderivednkcellenrichedimmunecellstopreventsevereinfectionafterlivertransplantation
AT shintarokuroda phaseiiistudyofadoptiveimmunotherapyusingdonorlivergraftderivednkcellenrichedimmunecellstopreventsevereinfectionafterlivertransplantation
AT hiroyukitahara phaseiiistudyofadoptiveimmunotherapyusingdonorlivergraftderivednkcellenrichedimmunecellstopreventsevereinfectionafterlivertransplantation
AT kentaroide phaseiiistudyofadoptiveimmunotherapyusingdonorlivergraftderivednkcellenrichedimmunecellstopreventsevereinfectionafterlivertransplantation
AT tsuyoshikobayashi phaseiiistudyofadoptiveimmunotherapyusingdonorlivergraftderivednkcellenrichedimmunecellstopreventsevereinfectionafterlivertransplantation
AT yukatanaka phaseiiistudyofadoptiveimmunotherapyusingdonorlivergraftderivednkcellenrichedimmunecellstopreventsevereinfectionafterlivertransplantation
AT junkotanaka phaseiiistudyofadoptiveimmunotherapyusingdonorlivergraftderivednkcellenrichedimmunecellstopreventsevereinfectionafterlivertransplantation
AT hidekiohdan phaseiiistudyofadoptiveimmunotherapyusingdonorlivergraftderivednkcellenrichedimmunecellstopreventsevereinfectionafterlivertransplantation